Form 4: QuidelOrtho CEO Brian Blaser Acquires Shares Through Trust

QuidelOrtho's President and CEO, Brian J. Blaser, acquired 6,033 shares of common stock through a trust on December 11, 2024.

Summary

• Brian J. Blaser, President and CEO of QuidelOrtho Corp, acquired 6,033 shares of the company's common stock.
• The transaction occurred on December 11, 2024.
• The shares were purchased at a price of $41.4186 per share.
• The acquisition was made indirectly through a trust.

Sentiment

Score: 6

Explanation: The document reflects a routine insider purchase, which is generally neutral to slightly positive. It indicates confidence from the CEO but is not a major market-moving event.

Positives

• The CEO's purchase of shares could be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• Similar filings are made by executives at comparable companies such as Abbott Laboratories, Danaher Corporation, and Becton Dickinson.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment, as it indicates confidence from the CEO.

Key Dates

Keywords

QuidelOrtho, Brian Blaser, insider trading, stock acquisition, executive purchase, common stock, trust